ETF Leaders Powered by the NYSE: FlexShares' Darek Wojnar
Inflation has been a defining theme this year, but ESG has managed to maintain its place on the center stage, each heavily influencing investors’ allocation decisions.
Source: etftrends.com
Page 3 - Current Perspective News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Current Perspective. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Current Perspective Today - Breaking & Trending Today
Janssen Pharmaceutica NV: Janssen Announces Treatment with ERLEADA?(apalutamide) Significantly Improved Overall Survival in Patients with Metastatic Hormone-Sensitive Prostate Cancer
Janssen Pharmaceutica NV: Janssen Announces Treatment with ERLEADA?(apalutamide) Significantly Improved Overall Survival in Patients with Metastatic Hormone-Sensitive Prostate Cancer FOR EMEA PHARMACEUTICAL TRADE AND MEDICAL MEDIA ONLY NOT FOR DISTRIBUTION IN BENELUX, SWEDEN AND ITALY Janssen Pharmaceutica NV (Janssen) announced today results from the final analysis of the Phase 3 TITAN study, which demonstrated the continued statistically significant benefit of apalutamide plus androgen deprivation therapy (ADT) in overall survival (OS) in patients with metastatic hormone-sensitive prostate ...
Source: finanznachrichten.de